修补破损心脏：心脏细胞疗法获得生物工程助力。
Patching up broken hearts: cardiac cell therapy gets a bioengineered boost.
机构信息
Stanford Cardiovascular Institute, Stanford, CA 94305, USA.
Stanford Cardiovascular Institute, Stanford, CA 94305, USA; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA; Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
出版信息
Cell Stem Cell. 2014 Dec 4;15(6):671-3. doi: 10.1016/j.stem.2014.11.008.
Abstract
Preclinical and clinical studies for cardiac cell therapy have only seen moderate success due to poor engraftment and survival of transplanted cells. In this issue of Cell Stem Cell, Ye et al. (2014) employ a growth-factor-loaded fibrin patch and show improved cardiovascular cell survival after cell transplantation into a porcine model of ischemia reperfusion.
摘要
由于移植细胞的植入和存活效果不佳，心脏细胞治疗的临床前和临床研究仅取得了中等成效。在本期的《Cell Stem Cell》杂志上，叶等人（2014）采用了载有生长因子的纤维蛋白贴，并在猪缺血再灌注模型中进行细胞移植后，观察到心血管细胞的存活率得到了提高。
相似文献
1
Patching up broken hearts: cardiac cell therapy gets a bioengineered boost.
Cell Stem Cell. 2014 Dec 4;15(6):671-3. doi: 10.1016/j.stem.2014.11.008.
2
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.
Cell Stem Cell. 2014 Dec 4;15(6):750-61. doi: 10.1016/j.stem.2014.11.009.
3
Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.
Circulation. 2018 Apr 17;137(16):1712-1730. doi: 10.1161/CIRCULATIONAHA.117.030785. Epub 2017 Dec 12.
4
HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction.
J Cardiovasc Transl Res. 2020 Feb;13(1):110-119. doi: 10.1007/s12265-019-09891-4. Epub 2019 May 31.
5
CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Circ Res. 2018 Jan 5;122(1):88-96. doi: 10.1161/CIRCRESAHA.117.311504. Epub 2017 Oct 10.
6
A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling.
Stem Cells. 2011 Feb;29(2):367-75. doi: 10.1002/stem.580.
7
Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.
Stem Cells Transl Med. 2016 Feb;5(2):141-51. doi: 10.5966/sctm.2015-0083. Epub 2015 Dec 18.
8
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
9
Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction.
Transplantation. 2019 Feb;103(2):291-298. doi: 10.1097/TP.0000000000002384.
10
Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.
Cardiovasc Res. 2009 Aug 1;83(3):527-35. doi: 10.1093/cvr/cvp146. Epub 2009 May 9.
引用本文的文献
1
Image-Guided Cardiac Regeneration via a 3D Bioprinted Vascular Patch with Built-in CT Visibility.
Chem Eng J. 2025 Sep 15;520. doi: 10.1016/j.cej.2025.165926. Epub 2025 Jul 12.
2
Macrophage Containing Cardiac Organoids for Studying Inflammatory Programmes Driving Cardiovascular Disease.
Curr Cardiol Rep. 2025 Jun 19;27(1):97. doi: 10.1007/s11886-025-02246-3.
3
Current status and future prospects of patient-derived induced pluripotent stem cells.
Hum Cell. 2021 Nov;34(6):1601-1616. doi: 10.1007/s13577-021-00592-2. Epub 2021 Aug 10.
4
Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?
Cells. 2021 Mar 13;10(3):641. doi: 10.3390/cells10030641.
5
Cardiovascular tissue bioprinting: Physical and chemical processes.
Appl Phys Rev. 2018 Dec;5(4):041106. doi: 10.1063/1.5048807.
6
Heart regeneration with human pluripotent stem cells: Prospects and challenges.
Bioact Mater. 2020 Jan 14;5(1):74-81. doi: 10.1016/j.bioactmat.2020.01.003. eCollection 2020 Mar.
7
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells.
Gene Ther. 2019 Aug;26(7-8):324-337. doi: 10.1038/s41434-019-0084-5. Epub 2019 Jun 25.
8
cardiac regeneration by using neuropeptide substance P and IGF-1C peptide eluting heart patches.
Regen Biomater. 2018 Oct;5(5):303-316. doi: 10.1093/rb/rby021. Epub 2018 Oct 12.
9
Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells.
Nat Biomed Eng. 2018 May;2(5):293-303. doi: 10.1038/s41551-018-0229-7. Epub 2018 Apr 23.
10
Contractile force generation by 3D hiPSC-derived cardiac tissues is enhanced by rapid establishment of cellular interconnection in matrix with muscle-mimicking stiffness.
Biomaterials. 2017 Jul;131:111-120. doi: 10.1016/j.biomaterials.2017.03.039. Epub 2017 Mar 30.
本文引用的文献
1
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.
Cell Stem Cell. 2014 Dec 4;15(6):750-61. doi: 10.1016/j.stem.2014.11.009.
2
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.
Nature. 2014 Jun 12;510(7504):273-7. doi: 10.1038/nature13233. Epub 2014 Apr 30.
3
Patching the heart: cardiac repair from within and outside.
Circ Res. 2013 Sep 13;113(7):922-32. doi: 10.1161/CIRCRESAHA.113.300216.
4
The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction.
Biomaterials. 2013 Dec;34(36):9048-55. doi: 10.1016/j.biomaterials.2013.08.017. Epub 2013 Aug 30.
5
Cardiac stem cell therapy and the promise of heart regeneration.
Cell Stem Cell. 2013 Jun 6;12(6):689-98. doi: 10.1016/j.stem.2013.05.008.
6
Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.
Circ Res. 2012 Aug 3;111(4):455-68. doi: 10.1161/CIRCRESAHA.112.269894. Epub 2012 Jun 21.
7
A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling.
Stem Cells. 2011 Feb;29(2):367-75. doi: 10.1002/stem.580.
8
Biomaterials for the treatment of myocardial infarction.
J Am Coll Cardiol. 2006 Sep 5;48(5):907-13. doi: 10.1016/j.jacc.2006.06.005. Epub 2006 Aug 17.
9
Autologous stem cell transplantation for myocardial repair.
Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H501-11. doi: 10.1152/ajpheart.00019.2004.
Zotero 插件